Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Accurate species discrimination based on a robust nuclear protein-coding gene marker is essential for Fasciola spp. because of the presence of F. hepatica, F. gigantica, and hybrid Fasciola flukes that originate from the interspecific hybridization between the two species in Asia. Molecular identification of Fasciola species uses multiplex polymerase chain reaction (PCR) targeting phosphoenolpyruvate carboxykinase (pepck) and PCR-restriction fragment length polymorphism (RFLP) targeting DNA polymerase delta (pold). However, these methods have demonstrated limitations, including misidentification errors. In this study, we aimed to investigate the reliability of multiplex PCR using the fatty acid binding protein type I (FABP type I) gene as a species identification marker. In this study, 75 liver flukes were determined as F. hepatica using FABP type I. FABP type I was more accurate and useful for species identification of F. hepatica than previously reported markers, pepck and pold, as no discrimination errors were observed, whereas misdiagnosis and amplification failure occurred in pepck and pold for five and 13 flukes, respectively. We also aimed to analyze the phylogeny of Turkish Fasciola flukes based on nucleotide sequences of the NADH dehydrogenase subunit 1 (nad1) gene of mitochondrial DNA. Notably, the Turkish F. hepatica population showed greater genetic diversity than the reference populations from the previous studies, suggesting that the Turkish population is much older. This supports the idea that F. hepatica originated in the Fertile Crescent, the area adjacent to Türkiye, as proposed previously.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.meegid.2025.105783DOI Listing

Publication Analysis

Top Keywords

fabp type
16
accurate species
12
type fabp
12
species discrimination
8
fatty acid
8
acid binding
8
binding protein
8
protein type
8
type gene
8
mitochondrial dna
8

Similar Publications

A novel rapid rule-out protocol for acute chest pain using H-FABP point-of-care testing.

Sci Rep

August 2025

Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, Salzburg, 5020, Austria.

Emergency department (ED) visits have gradually increased throughout recent years, contributing to the widespread problem of ED overcrowding. The purpose of this study was to develop a rapid rule-out strategy for patients with acute chest pain that integrates clinical characteristics and Heart-type fatty acid binding protein (H-FABP) to improve ED patient care. H-FABP point-of-care test results of 130 patients were integrated into a modified HEART score, with a score ≤ 3 points indicating rule-out of acute coronary syndrome (ACS).

View Article and Find Full Text PDF

Perfluorooctanesulfonate (PFOS) is a persistent environmental pollutant in the per- and polyfluoroalkyl substances (PFAS) class, known to accumulate in the liver and trigger hepatotoxicity. While studies suggested that fatty acid-binding proteins (FABPs) drive the hepatic accumulation of PFAS, evidence is entirely lacking. Using wild-type and mice with global deletion of liver-type and intestine-type FABP (L-FABP, I-FABP), we measured PFOS toxicokinetics by administering single oral doses (0.

View Article and Find Full Text PDF

Introduction: Shenfu injection (SFI) is widely used in clinical severe conditions including sepsis due to its pharmacological effects of invigorating Qi and reviving Yang for resuscitation. SFI is known to alleviate sepsis-related intestinal injury. However, the underlying mechanism remains exclusive.

View Article and Find Full Text PDF

[Research progress on the biomarkers of sepsis-induced cardiomyopathy].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue

June 2025

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China.

Sepsis constitutes one of the principal causes of death globally, and the mortality rate of patients complicated with sepsis-induced cardiomyopathy (SIC) surges by over 50%. Early identification of patients with sepsis, particularly SIC, and implementing clinical intervention are vital measures to reduce the mortality. In recent years, biomarkers for the diagnosis and prognosis of SIC have emerged rapidly.

View Article and Find Full Text PDF

We investigate the role of prokineticin, T-reg cells, and oxidative metabolism in the progression of obesity-related NASH to HCC. Our findings on a cohort of 250 patients, including Obese NAFLD and Non-Obese NAFLD, reveal significant insights. In Obese NAFLD, PK-1 mRNA expression was reduced by 2.

View Article and Find Full Text PDF